Reblozyl

Indicated For

anemia in myelodysplastic syndromes (MDS), anemia in beta thalassemia

About This Medication

# BMS Access Support® Patient Guide: How to Get Reblozyl® (luspatercept-aamt) at Low or No Cost Reblozyl® (luspatercept-aamt) is a prescription medication used to treat anemia in adults with certain blood disorders, including myelodysplastic syndromes (MDS) with ring sideroblasts or beta-thalassemia dependent on red blood cell transfusions. Bristol Myers Squibb (BMS) offers the **BMS Access Support®** program, which provides **co-pay assistance** for eligible commercially insured patients, helping reduce out-of-pocket costs like deductibles, co-pays, or co-insurance. There is **no free medication program** directly from BMS for Reblozyl, but uninsured or government-insured patients may qualify for free medication through the independent **Bristol Myers Squibb Patient Assistance Foundation (BMSPAF)**.[1][2][3][7][10] ## About Reblozyl® (luspatercept-aamt) **Reblozyl** is an injectable therapy administered by a healthcare professional every 3 weeks to help increase red blood cell production and reduce the need for transfusions in patients with specific types of anemia. It's FDA-approved for: - Anemia in adults with very low- to intermediate-risk MDS with ring sideroblasts who require ≥2 red blood cell units per 8 weeks. - Anemia in adults with beta-thalassemia who require regular transfusions.[1][6] Common side effects include fatigue, joint pain, dizziness, and diarrhea. Always discuss risks and benefits with your doctor. Reblozyl is typically covered by insurance but can have high out-of-pocket costs without assistance.[1][3] ## Who Qualifies for Assistance? The BMS Access Support® program focuses on **co-pay help** rather than free drug provision. Qualification is based on insurance type, not income: - **Primary Program (Co-Pay Assistance):** For **commercially insured patients** (private insurance like employer plans or marketplace coverage) whose plan covers Reblozyl but leaves high co-pays/co-insurance.[1][3][5][7] - **Coverage:** Up to **$10,000 per calendar year** per dose for Reblozyl, potentially reducing co-pay to **$0**.[7][8] - **Exclusions:** Patients with **government insurance** (Medicare, Medicaid, TRICARE) are **not eligible** for co-pay help but can get referrals to independent foundations.[5] - **BMSPAF for Free Medication:** Independent foundation for **uninsured, underinsured, or government-insured** patients meeting income guidelines (specific % of Federal Poverty Level, not detailed here). Provides free Reblozyl for up to 1 year, shipped to doctor's office or home.[2][10] **Live in the US or Puerto Rico** and be 18+ years old. Program does not guarantee approval or coverage.[4][10] ## Income Eligibility Breakdown BMS Access Support® **co-pay program has no income limits**—it's for commercially insured patients regardless of income. However, the independent **BMSPAF** for free medication **is income-based** (needs-based, typically 400-500% FPL, but confirm via phone as exact thresholds vary by medication).[10] | Household Size | Estimated BMSPAF Income Limit (Annual, ~400% FPL example)* | Notes | |-|-|-| | Individual | ~$60,000 | Co-pay program: No income check[1][3] | | Couple | ~$81,000 | BMSPAF: Uninsured/underinsured only[10] | | Family of 3 | ~$102,000 | Government insurance may qualify for BMSPAF[5][10] | | Family of 4 | ~$123,000 | Reapply annually[10] | *Estimates based on 2026 FPL; call 1-800-861-0048 for exact Reblozyl guidelines. Co-pay program ignores income.[7] ## Insurance Requirements - **Commercial/Private Insurance:** Eligible for co-pay card/assistance (up to $10,000/year). Insurance must cover Reblozyl.[3][7][8] - **Medicare/Medicaid/TRICARE:** **Not eligible** for BMS co-pay program. Directed to independent foundations like BMSPAF via BMS Access Support.[5] - **Uninsured:** No co-pay help; apply to BMSPAF for free drug.[2][10] BMS offers **benefit investigation** to check your coverage and **prior authorization support**.[3][9] ## Step-by-Step Application Process 1. **Talk to Your Doctor:** Confirm Reblozyl prescription and ask about BMS Access Support®. They can download prior auth resources.[1][3] 2. **Call BMS Access Support®:** Dial **1-800-861-0048** (8am-8pm ET, Mon-Fri). Speak to a Patient Access Specialist for: - Benefits check - Co-pay eligibility - BMSPAF referral if needed - Application guidance[1][3][5] 3. **Get Co-Pay Card (Commercial Insurance):** If eligible, receive instant e-card or physical card. Use at pharmacy/infusion center for $0 co-pay (up to cap).[7][8] 4. **BMSPAF Application (Free Drug):** Download enrollment form online or via phone. Submit proof of income, residency, prescription. No insurance required.[10] 5. **Healthcare Provider Help:** Doctor completes any reimbursement forms. BMS assists with appeals.[9] No online application portal specified; phone is primary method.[1] ## Timeline and Delivery - **Co-Pay Approval:** Often **immediate** via phone; card activated same day.[8] - **BMSPAF Approval:** Processing time not specified; typically 2-4 weeks based on similar programs. Coverage up to **12 months** (reapply annually; Medicare patients reapply Jan).[10] - **Delivery:** Co-pay doesn't affect delivery—get via pharmacy/doctor. BMSPAF ships **90-day supply** to doctor's office or home.[10] - **Refills:** Co-pay valid calendar year; track cap. BMSPAF requires annual re-enrollment.[7][10] Call for status updates.[1] ## Alternatives if Denied or Ineligible - **Appeal Insurance Denial:** BMS helps with prior auth/appeals.[3] - **Independent Foundations:** HealthWell, PAN Foundation, or Patient Access Network (call BMS for matches).[5] - **State Programs:** Check Medicaid extra help or generic alternatives (none listed as biosimilars).[ ] - **Manufacturer Switch:** No biosimilars for Reblozyl.[ ] - **Clinical Trials:** Ask doctor about trials via ClinicalTrials.gov. ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, benefits, and terms can change. BMS makes **no guarantees** of approval, reimbursement, or savings. Consult your healthcare provider, call **1-800-861-0048**, or visit product sites for latest details. Not affiliated with government programs. Track taxes—co-pay cards may have implications.

Program information last verified: March 30, 2026